Revolution Medicines, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-147.2M | $-153.7M | $6.5M | $20.7M |
| FY2022 | $-224.4M | $-235.2M | $10.8M | $31.2M |
| FY2023 | $-350.6M | $-358.3M | $7.7M | $61.8M |
| FY2024 | $-557.4M | $-567.7M | $10.3M | $79.2M |
| FY2025 | $-897.7M | $-913.7M | $16.0M | $118.4M |